EC
EcoR1 Capital’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.6M | Hold |
1,389,276
| – | – | 4% | 7 |
|
|
2025
Q1 | $47.3M | Hold |
1,389,276
| – | – | 2.8% | 9 |
|
|
2024
Q4 | $54.7M | Hold |
1,389,276
| – | – | 2.07% | 13 |
|
|
2024
Q3 | $65.3M | Hold |
1,389,276
| – | – | 2.23% | 12 |
|
|
2024
Q2 | $75M | Hold |
1,389,276
| – | – | 2.3% | 14 |
|
|
2024
Q1 | $94.7M | Buy |
+1,389,276
| New | +$94.7M | 2.4% | 15 |
|
|
2022
Q1 | – | Sell |
-1,077,483
| Closed | -$81.7M | – | 88 |
|
|
2021
Q4 | $81.7M | Buy |
+1,077,483
| New | +$81.7M | 2.6% | 11 |
|
|
2020
Q2 | – | Sell |
-30,510
| Closed | -$1.29M | – | 49 |
|
|
2020
Q1 | $1.29M | Buy |
+30,510
| New | +$1.29M | 0.14% | 42 |
|
|
2019
Q3 | – | Sell |
-1,610,250
| Closed | -$75.8M | – | 36 |
|
|
2019
Q2 | $75.8M | Sell |
1,610,250
-268,027
| -14% | -$12.6M | 7.66% | 4 |
|
|
2019
Q1 | $67.1M | Buy |
1,878,277
+1,669,427
| +799% | +$59.6M | 6.18% | 4 |
|
|
2018
Q4 | $5.97M | Sell |
208,850
-291,150
| -58% | -$8.32M | 0.6% | 32 |
|
|
2018
Q3 | $22.2M | Buy |
+500,000
| New | +$22.2M | 2% | 13 |
|